Molecular epidemiology, evolution and phylogeny of Chikungunya virus: An updating review

Infection, Genetics and Evolution

Volumn 41, Issue , 2016, Pages 270-278

  Lo Presti, Alessandra ^a   Cella, Eleonora ^a,b   Angeletti, Silvia ^c   Ciccozzi, Massimo ^a,c  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

Chikungunya virus (CHIKV); Epidemiology; Phylogenesys; Therapy; Vaccines

Indexed keywords

DNA VACCINE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 5F10; MONOCLONAL ANTIBODY 8B10; RECOMBINANT VACCINE; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; VIRUS VACCINE; ANTIVIRUS AGENT; VIRUS ENVELOPE PROTEIN;

ANTIVIRAL THERAPY; CHIKUNGUNYA; DRUG EFFICACY; DRUG SAFETY; ENVIRONMENTAL FACTOR; EPIDEMIC; HUMAN; MEDICATION THERAPY MANAGEMENT; MOLECULAR EPIDEMIOLOGY; MOLECULAR EVOLUTION; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; REVIEW; VACCINATION; VACCINE PRODUCTION; VIRUS GENOME; VIRUS LIKE AGENT; VIRUS REPLICATION; VIRUS TRANSMISSION; ANIMAL; BIOSYNTHESIS; CHIKUNGUNYA FEVER; CHIKUNGUNYA VIRUS; CLASSIFICATION; DRUG EFFECTS; EVOLUTION; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; INSECT VECTOR; MOSQUITO; PATHOGENICITY; VIROLOGY;

ANIMALS; ANTIVIRAL AGENTS; BIOLOGICAL EVOLUTION; CHIKUNGUNYA FEVER; CHIKUNGUNYA VIRUS; CULICIDAE; GENOME, VIRAL; HOST-PATHOGEN INTERACTIONS; HUMANS; INSECT VECTORS; MOLECULAR EPIDEMIOLOGY; PHYLOGENY; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

EID: 84964319891     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2016.04.006     Document Type: Review

References (112)

1. Abdelnabi R., Neyts J., Delang L. Towards antivirals against chikungunya virus. Antiviral Res. 2015, 121:59-68.
2. Abraham R., Manakkadan A., Mudaliar P., Joseph I., Sivakumar K.C., Nair R.R., Sreekumar E. Correlation of phylogenetic clade diversification and in vitro infectivity differences among Cosmopolitangenotype strains of Chikungunya virus. Infect. Genet. Evol. 2016, 37:174-184.
3. Adebajo A.O. Rheumatic manifestations of tropical diseases. Curr. Opin. Rheumatol. 1996, 8:85-89.
4. Akahata W., Yang Z.Y., Andersen H., Sun S., Holdaway H.A., Kong W.P., Lewis M.G., Higgs S., Rossmann M.G., Rao S., Nabel G.J. A virus-like particle vaccine for epidemic chikungunya virus protects non human primates against infection. Nat. Med. 2010, 16:334-338.
5. Alibert A., Pfannstiel A., Grangeon J.P. Chikungunya outbreak in New Caledonia in 2011, Status report as at 22 August 2011. Inform'Action 2011, 34:3-9.
6. Azevedo Rdo S., Oliveira C.S., Vasconcelos P.F. Chikungunya risk for Brazil. Rev. Saude Publica 2015, 49:58.
7. Bacaër N. Approximation of the basic reproduction number R0 for vector-borne diseases with a periodic vector population. Bull. Math. Biol. 2007, 69:1067-1091.
8. Barrera-Cruz A., Díaz-Ramos R.D., Viniegra-Osorio A., Grajales-Muñiz C., Dávila-Torres J. Technical guidelines for the prevention and treatment of chikungunya fever. Rev. Med. Inst. Mex. Seguro Soc. 2015, 53:102-119.
9. Barzon L., Squarzon L., Cattai M., Franchin E., Pagni S., Cusinato R., Palu G. West Nile virus infection in Veneto region, Italy, 2008-2009. Euro Surveill. 2009, 14. (pii=19289).
10. Bassetto M., De Burghgraeve T., Delang L., Massarotti A., Coluccia A., Zonta N., Gatti V., Colombano G., Sorba G., Silvestri R., Tron G.C., Neyts J., Leyssen P., Brancale A. Computer-aided identification, design and synthesis of a novel series of compounds with selective antiviral activity against chikungunya virus. Antivir. Res. 2013, 98:12-18.
11. Basmadjian C., Thuaud F., Ribeiro N., Desaubry L. Flavaglines: potent anticancer drugs that target prohibitins and the helicase eIF4A. Future Med. Chem. 2013, 5:2185-2197.
12. Bernard E., Solignat M., Gay B., Chazal N., Higgs S., Devaux C., Briant L. Endocytosis of chikungunya virus into mammalian cells: role of clathrin and early endosomal compartments. PLoS ONE 2010, 5.
13. Bhagwati C., M M., Mehta K.D., G.Y.S. Profile of the Chikungunya infection: a neglected vector borne disease which is prevalent in the Rajkot district. J. Clin. Diagn. Res. 2013, 7:1008-1011.
14. Boelle P.Y., Thomas G., Vergu E., Renault P., Valleron A.J., Flahault A. Investigating transmission in a two-wave epidemic of Chikungunya fever, Reunion Island. Vector Borne Zoonotic Dis. 2008, 8:207-217.
15. Bon I., Ciccozzi M., Zehender G., Biagetti C., Verrucchi G., Lai A., Lo Presti A., Gibellini D., Re M.C. HIV-1 subtype C transmission network: the phylogenetic reconstruction strongly supports the epidemiological data. J. Clin. Virol. 2010, 48:212-214.
16. Bouquillard E., Combe B. A report of 21 cases of rheumatoid arthritis following Chikungunya fever. A mean follow-up of two years. Joint Bone Spine 2009, 76:654-657.
17. Bourjot M., Leyssen P., Neyts J., Dumontet V., Litaudon M. Trigocherrierin a, a potent inhibitor of chikungunya virus replication. Molecules 2014, 19:3617-3627.
18. Brazilian Health Portal Boletim Epidemiológico http://portalsaude.saude.gov.br/.
19. Briolant S., Garin D., Scaramozzino N., Jouan A., Crance J.M. In vitro inhibition of Chikungunya and Semliki Forest viruses replication by antiviral compounds: synergistic effect of interferon-alpha and ribavirin combination. Antiviral Res. 2004, 61:111-117.
20. Carbajo A.E., Vezzani D. Waiting for chikungunya fever in Argentina: spatio-temporal risk maps. Mem. Inst. Oswaldo Cruz 2015, 110:259-262.
21. Cassadou S., Boucau S., Petit-Sinturel M., Huc P., Leparc-Goffart I., Ledrans M. Emergence of chikungunya fever on the French side of Saint Martin island, October to December 2013. Euro Surveill. 2014, 19:20752.
22. Centers for Disease Control and Prevention Chikungunya in the Americas http://www.cdc.gov/chikungunya/geo/americas.html.
23. Cha G.W., Cho J.E., Lee E.J., Ju Y.R., Han M.G., Park C., Jeong Y.E. Travel-associated Chikungunya cases in South Korea during 2009-2010. Osong Public Health Res. Perspect. 2013, 4:170-175.
24. Chattopadhyay A., Wang E., Seymour R., Weaver S.C., Rose J.K. A chimeric vesiculo/alphavirus is an effective alphavirus vaccine. J. Virol. 2013, 87:395-402.
25. Chu H., Das S.C., Fuchs J.F., Suresh M., Weaver S.C., Stinchcomb D.T., Partidos C.D., Osorio J.E. Deciphering the protective role of adaptive immunity to CHIKV/IRES a novel candidate vaccine against Chikungunya in the A129 mouse model. Vaccine 2013, 31:3353-3360.
26. Ciccozzi M., Lai A., Ebranati E., Gabanelli E., Galli M., Mugosa B., Vratnica Z., Vujoševic D., Lauševic D., Ciotti M., Cella E., Lo Presti A., Zehender G. Phylogeographic reconstruction of HIV Type 1B in Montenegro and the Balkan Region. AIDS Res. Hum. Retrovir. 2012, 28:1280-1284.
27. Ciccozzi M., Lo Presti A., Cella E., Giovanetti M., Lai A., El-Sawaf G., Faggioni G., Vescio F., Al Ameri R., De Santis R., Helaly G., Pomponi A., Metwally D., Fantini M., Qadi H., Zehender G., Lista F., Rezza G. Phylogeny of dengue and Chikungunya viruses in Al Hudayda governorate, Yemen. Infect. Genet. Evol. 2014, 27:395-401.
28. Cleton N.B., Reusken C.B., Wagenaar J.F., van der Vaart E.E., Reimerink J., van der Eijk A.A., Koopmans M.P. Syndromic approach to arboviral diagnostics for global travelers as a basis for infectious disease surveillance. PLoS Negl. Trop. Dis. 2015, 9.
29. Coffey L.L., Forrester N., Tsetsarkin K., Vasilakis N., Weaver S.C. Factors shaping the adaptive landscape for arboviruses: implications for the emergence of disease. Future Microbiol 2013, 8:155-176.
30. Chopra A., Saluja M., Venugopalan A. Effectiveness of chloroquine and inflammatory cytokine response in patients with early persistent musculoskeletal pain and arthritis following chikungunya virus infection. Arthritis Rheumatol. 2014, 66:319-326.
31. Couderc T., Khandoudi N., Grandadam M., Visse C., Gangneux N., Bagot S., Prost J.F., Lecuit M. Prophylaxis and therapy for Chikungunya virus infection. J. Infect. Dis. 2009, 15(200(4)):516-523.
32. Dash P.K., Tiwari M., Santhosh S.R., Parida M., Lakshmana Rao P.V. RNA interference mediated inhibition of Chikungunya virus replication in mammalian cells. Biochem. Biophys. Res. Commun. 2008, 376:718-722.
33. Delisle E., Rousseau C., Broche B., Leparc-Goffart I., L'Ambert G., Cochet A., Prat C., Foulongne V., Ferre J.B., Catelinois O., Flusin O., Tchernonog E., Moussion I.E., Wiegandt A., Septfons A., Mendy A., Moyano M.B., Laporte L., Maurel J., Jourdain F., Reynes J., Paty M.C., Golliot F. Chikungunya outbreak in Montpellier, France, September to October 2014. Euro Surveill. 2015, 20.
34. Deller J.J., Russell P.K. An analysis of fevers of unknown origin in American soldiers in Vietnam. Ann. Intern. Med. 1967, 66:1129-1143.
35. Delogu I., Pastorino B., Baronti C., Nougairède A., Bonnet E., de Lamballerie X. In vitro antiviral activity of arbidol against chikungunya virus and characteristics of a selected resistant mutant. Antiviral Res. 2011, 90:99-107.
36. Díaz Y., Carrera J.P., Cerezo L., Arauz D., Guerra I., Cisneros J., Armién B., Botello A.M., Araúz A.B., Gonzalez V., López Y., Moreno L., López-Vergès S., Moreno B.A. Chikungunya virus infection: first detection of imported and autochthonous cases in Panama. Am.J.Trop. Med. Hyg. 2015, 92:482-485.
37. Drummond A., Pybus O.G., Rambaut A. Inference of viral evolutionary rates from molecular sequences. Adv. Parasitol. 2003, 54:331-358.
38. Dumont Y., Chiroleu F. Vector control for the Chikungunya disease. Math. Biosci. Eng. 2010, 7:313-345.
39. Fischer M., Staples J.E. Arboviral Diseases Branch, National Center for Emerging and Zoonotic Infectious Diseases, CDC. Notes from the field: chikungunya virus spreads in the Americas-Caribbean and South America, 2013-2014. MMWR Morb. Mortal. Wkly Rep. 2014, 63:500-501.
40. Fric J., Bertin-Maghit S., Wang C.I., Nardin A., Warter L. Use of human monoclonal antibodies to treat Chikungunya virus infection. J. Infect. Dis. 2013, 207:319-322.
41. Garg M., Alcalde V. Update on Emerging Infections: News From the Centers for Disease Control and Prevention. Annals of Emergency Medicine, INFECTIOUS DISEASE/CDC UPDATE 2014, 64:5.
42. Giovanetti M., Milano T., Alcantara L.C., Carcangiu L., Cella E., Lai A., Lo Presti A., Pascarella S., Zehender G., Angeletti S., Ciccozzi M. Zika virus spreading in South America: evolutionary analysis of emerging neutralizing resistant Phe279Ser strains. Asian Pac. J. Trop. Med. 2016, (in press).
43. Goh L.Y., Hobson-Peters J., Prow N.A., Gardner J., Bielefeldt-Ohmann H., Pyke A.T., Suhrbier A., Hall R.A. Neutralizing monoclonal antibodies to the e2 protein of chikungunya virus protects against disease in a mouse model. Clin. Immunol. 2013, 149(3):487-497.
44. Gudo E.S., Pinto G., Vene S., Mandlaze A., Muianga A.F., Cliff J., Falk K. Serological evidence of chikungunya virus among acute febrile patients in Southern Mozambique. PLoS Negl. Trop. Dis. 2015, 9.
45. Gupta D.K., Kaur P., Leong S.T., Tan L.T., Prinsep M.R., Chu J.J.H. Antichikungunya viral activities of aplysiatoxin-related compounds from the marine cyanobacterium Trichodesmium erythraeum. Mar. Drugs 2014, 12:115-127.
46. Hallengärd D., Kakoulidou M., Lulla A., Kümmerer B.M., Johansson D.X., Mutso M., Lulla V., Fazakerley J.K., Roques P., Le Grand R., Merits A., Liljeström P. Novel attenuated Chikungunya vaccine candidates elicit protective immunity in C57BL/6 mice. J Virol. 2014 Mar, 88(5):2858-2866.
47. Higashi N., Matsumoto A., Tabata K., Nagatomo Y. Electron microscope study of development of Chikungunya virus in green monkey kidney stable (VERO) cells. Virology 1967, 33:55-69.
48. Hoke C.H., Pace-Templeton J., Pittman P., Malinoski F.J., Gibbs P., Ulderich T., Mathers M., Fogtman B., Glass P., Vaughn D.W. US military contributions to the global response to pandemic chikungunya. Vaccine 2012, 30:6713-6720.
49. Horwood P.F., Reimer L.J., Dagina R., Susapu M., Bande G., Katusele M., Koimbu G., Jimmy S., Ropa B., Siba P.M., Pavlin B.I. Outbreak of chikungunya virus infection, Vanimo, Papua New Guinea. Emerg. Infect. Dis. 2013, 19:1535-1538.
50. Johansson M.A., Powers A.M., Pesik N., Cohen N.J., Staples J.E. Nowcasting the spread of chikungunya virus in the Americas. PLoS ONE 2014, 9.
51. Kaur P., Chu J.J.H. Chikungunya virus: an update on antiviral development and challenges. Drug Discov. Today 2013, 18:969-983.
52. Kaur P., Thiruchelvan M., Lee R.C., Chen H., Chen K.C., Ng M.L., Chu J.J. Inhibition of chikungunya virus replication by harringtonine, a novel antiviral that suppresses viral protein expression. Antimicrob. Agents Chemother. 2013, 57:155-167.
53. Kautz T.F., Díaz-González E.E., Erasmus H., Malo-García I.R., Langsjoen R.M., Patterson E.I., Auguste D.I., Forrester N.L., Sanchez-Casas R.M., Hernández-Ávila M., Alpuche-Aranda C.M., Weaver S.C., Fernández-Salas I. Chikungunya virus as cause of febrile illness outbreak, Chiapas, Mexico, 2014. Emerg. Infect. Dis. 2015, 21:2070-2073.
54. Kendrick K., Stanek D., Blackmore C., Centers for Disease Control and Prevention (CDC) Notes from the field: transmission of chikungunya virus in the continental United States-Florida, 2014. MMWR Morb. Mortal. Wkly Rep. 2014, 63:1137.
55. Khan M., Santhosh S.R., Tiwari M., Lakshmana Rao P.V., Parida M. Assessment of in vitro prophylactic and therapeutic efficacy of chloroquine against chikungunya virus in Vero cells. J. Med. Virol. 2010, 82:817-824.
56. Khan M., Dhanwani R., Patro I.K., Rao P.V., Parida M.M. Cellular IMPDH enzyme activity is a potential target for the inhibition of Chikungunya virus replication and virus induced apoptosis in cultured mammalian cells. Antiviral Res. 2011, 89:1-8.
57. Kramer R.M., Zeng Y., Sahni N., Kueltzo L.A., Schwartz R.M., Srivastava I.K., Crane L., Joshi S.B., Volkin D.B., Middaugh C.R. Development of a stable virus-like particle vaccine formulation against Chikungunya virus and investigation of the effects of polyanions. J. Pharm. Sci. 2013, 102:4305-4314.
58. Kumar M., Sudeep A.B., Arankalle V.A. Evaluation of recombinant E2 protein-based and whole-virus inactivated candidate vaccines against chikungunyavirus. Vaccine 2012, 30:6142-6149.
59. Ligon B.L. Reemergence of an unusual disease: the chikungunya epidemic. Semin. Pediatr. Infect. Dis. 2006, 17:99-104.
60. Lo Presti A., Ciccozzi M., Cella E., Lai A., Simonetti F.R., Galli M., Zehender G., Rezza G. Origin, evolution, and phylogeography of recent epidemic CHIKV strains. Infect. Genet. Evol. 2012, 12:392-398.
61. Lo Presti A., Lai A., Cella E., Zehender G., Ciccozzi M. Chikungunya virus, epidemiology, clinics and phylogenesis: a review. Asian Pac J Trop Med 2014, 7:925-932.
62. Mallilankaraman K., Shedlock D.J., Bao H., Kawalekar O.U., Fagone P., Ramanathan A.A., Ferraro B., Stabenow J., Vijayachari P., Sundaram S.G., Muruganandam N., Sarangan G., Srikanth P., Khan A.S., Lewis M.G., Kim J.J., Sardesai N.Y., Muthumani K., Weiner D.B. A DNA vaccine against chikungunya virus is protective in mice and induces neutralizing antibodies in mice and nonhuman primates. PLoS Negl. Trop. Dis. 2011, 5(1):11. e928.
63. McGill P.E. Viral infections: alpha-viral arthropathy. Baillieres Clin. Rheumatol. 1995, 9:145-150.
64. Metz S.W., Gardner J., Geertsema C., Le T.T., Goh L., Vlak J.M., Suhrbier A., Pijlman G.P. Effective chikungunya virus-like particle vaccine produced in insect cells. PLoS Negl. Trop. Dis. 2013, 7.
65. Miner J.J., Aw Yeang H.X., Fox J.M., Taffner S., Malkova O.N., Oh S.T., Kim A.H., Diamond M.S., Lenschow D.J., Yokoyama W.M. Chikungunya viral arthritis in the United States: a mimic of seronegative rheumatoid arthritis. Arthritis Rheum. 2015, 67:1214-1220.
66. Morrison T.E. Reemergence of chikungunya virus. J. Virol. 2014, 88:11644-11647.
67. Mudurangaplar B., Peerapur B.V. Seroepidemiological survey of Chikungunya in and around the regions of Bijapur (Vijayapura-North Karnataka). J. Clin. Diagn. Res. 2015, 9:DC01-DC02.
68. Narayan S., Kumudini T.S., Mariraj J., Krishna S. The prevalence of chikungunya arboviral infection in and around bellary district, karnataka. J. Evol. Dent. Med. Sci. 2012, 1:677-681.
69. Nunes M.R., Faria N.R., de Vasconcelos J.M., Golding N., Kraemer M.U., de Oliveira L.F., Azevedo Rdo S., da Silva D.E., da Silva E.V., da Silva S.P., Carvalho V.L., Coelho G.E., Cruz A.C., Rodrigues S.G., Vianez J.L., Nunes B.T., Cardoso J.F., Tesh R.B., Hay S.I., Pybus O.G., Vasconcelos P.F. Emergence and potential for spread of Chikungunya virus in Brazil. BMC Med. 2015, 13:102.
70. Omarjee R., Prat C., Flusin O., Boucau S., Tenebray B., Merle O., Huc-Anais P., Cassadou S., Leparc-Goffart I. Importance of case definition to monitor ongoing outbreak of chikungunya virus on a background of activelycirculating dengue virus, St Martin, December 2013 to January 2014. Euro Surveill. 2014, 19:20753.
71. Ozden S., Lucas-Hourani M., Ceccaldi P.E., Basak A., Valentine M., Benjannet S., Hamelin J., Jacob Y., Mamchaoui K., Mouly V., Despres P., Gessain A. Inhibition of Chikungunya virus infection in cultured human muscle cells by furin inhibitors: impairment of the maturation of the E2 surface glycoprotein. J. Biol. Chem. 2008, 283:21899-21908.
72. Pan American Health Organization Number of Reported Cases of Chikungunya Fever in the Americas by Country or Territory 2015, (Available from: paho.org).
73. Partidos C.D., Paykel J., Weger J., Borland E.M., Powers A.M., Seymour R., Weaver S.C., Stinchcomb D.T., Osorio J.E. Cross-protective immunity against o'nyong-nyong virus afforded by a novel recombinant chikungunya vaccine. Vaccine 2012, 30:4638-4643.
74. Pialoux G., Gauzere B.A., Jaureguiberry S., Strobel M. Chikungunya, an epidemic arbovirosis. Lancet Infect. Dis. 2007, 7:319-327.
75. Pierro A., Landini M.P., Gaibani P., Rossini G., Vocale C., Finarelli A.C., Cagarelli R., Sambri V., Varani S. A model of laboratory surveillance for neuro-arbovirosis applied during 2012 in the Emilia-Romagna region, Italy. Clin. Microbiol. Infect. 2014, 20:672-677.
76. Plante K., Wang E., Partidos C.D., Weger J., Gorchakov R., Tsetsarkin K., Borland E.M., Powers A.M., Seymour R., Stinchcomb D.T., Osorio J.E., Frolov I., Weaver S.C. Novel chikungunya vaccine candidate with an IRES-based attenuation and host range alteration mechanism. PLoS Pathog. 2011, 7.
77. Poletti P., Messeri G., Ajelli M., Vallorani R., Rizzo C., Merler S. Transmission potential of Chikungunya virus and control measures: the case of Italy. PLoS ONE 2011, 6.
78. Powers A.M., Brault A.C., Shirako Y., Strauss E.G., Kang W., Strauss J.H., Weaver S.C. Evolutionary relationships and systematics of the alphaviruses. J. Virol. 2001, 75:10118-10131.
79. Pohjala L., Utt A., Varjak M., Lulla A., Merits A., Ahola T., Tammela P. Inhibitors of alphavirus entry and replication identified with a stable Chikungunya replicon cell line and virus-based assays. PLoS One 2011, 6. e28923.
80. Polier G., Neumann J., Thuaud F., Ribeiro N., Gelhaus C., Schmidt H., Giaisi M., Kohler R., Muller W.W., Proksch P., Leippe M., Janssen O., Desaubry L., Krammer P.H., Li-Weber M. The natural anticancer compounds rocaglamides inhibit the Raf-MEK-ERK pathway by targeting prohibitin 1 and 2. Chem. Biol. 2012, 19:1093-1104.
81. Reller M.E., Akoroda U., Nagahawatte A., Devasiri V., Kodikaarachchi W., Strouse J.J., Chua R., Hou Y., Chow A., Sessions O.M., Østbye T., Gubler D.J., Woods C.W., Bodinayake C. Chikungunya as a cause of acute febrile illness in southern Sri Lanka. PLoS ONE 2013, 8.
82. Renault P., Solet J.L., Sissoko D., Balleydier E., Larrieu S., Filleul L., Lassalle C., Thiria J., Rachou E., de Valk H., Ilef D., Ledrans M., Quatresous I., Quenel P., Pierre V. A major epidemic of chikungunya virus infection on Reunion Island, France, 2005-2006. Am.J.Trop. Med. Hyg. 2007, 77:727-731.
83. Rizzo C., Vescio F., Declich S., Finarelli A.C., Macini P., Mattivi A., Rossini G., Piovesan C., Barzon L., Palù G., Gobbi F., Macchi L., Pavan A., Magurano F., Ciufolini M.G., Nicoletti L., Salmaso S., Rezza G. West Nile virus transmission with human cases in Italy, August-September 2009. Euro Surveill. 2009, 14. (pii=19353).
84. Robinson M.C. An epidemic of virus disease in southern province, Tanganyika territory, in 1952-53. Trans. R. Soc. Trop. Med. Hyg. 1955, 49:28-32.
85. Roques P., Joubert C., Delache B., Calvo J., Morin J., Martinon F., Lebon P., Cherel Y., Larcher T., Aumont G., de Lamballerie X., Le Grand R. Effet adverse d'un traitement à la chloroquine sur l'infection à Chikungunya dans le modèle macaque/ChikV OPY1. Presented at Colloque Chikungunya and arbovirosis, La Réunion, INC 2007, http://prodinra.inra.fr/record/147898.
86. Rossini G., Cavrini F., Pierro A., Macini P., Finarelli A., Po C., Peroni G., Di Caro A., Capobianchi M., Nicoletti L., Landini M., Sambri V. First human case of West Nile virus neuroinvasive infection in Italy, September 2008-case report. Euro Surveill. 2008, 13. (pii=19002).
87. Rothan H.A., Bahrani H., Mohamed Z., Teoh T.C., Shankar E.M., Rahman N.A. A combination of doxycycline and ribavirin alleviated chikungunya infection. PLoS ONE 2015, 10(5).
88. Roth A., Hoy D., Horwood P.F., Ropa B., Hancock T., Guillaumot L., Rickart K., Frison P., Pavlin B., Souares Y. Preparedness for threat of chikungunya in the pacific. Emerg. Infect. Dis. 2014, 20.
89. Sahadeo N., Mohammed H., Allicock O.M., Auguste A.J., Widen S.G., Badal K., Pulchan K., Foster J.E., Weaver S.C., Carrington C.V. Molecular characterisation of chikungunya virus infections in Trinidad and comparison of clinical and laboratory features with dengue and other acute febrile cases. PLoS Negl. Trop. Dis. 2015, 9.
90. Sahu A., Das B., Das M., Patra A., Biswal S., Kar S.K., Hazra R.K. Genetic characterization of E2 region of Chikungunya virus circulating in Odisha, Eastern India from 2010 to 2011. Infect. Genet. Evol. 2013, 18:113-124.
91. Saswat T., Kumar A., Kumar S., Mamidi P., Muduli S., Debata N.K., Pal N.S., Pratheek B.M., Chattopadhyay S., Chattopadhyay S. High rates of co-infection of dengue and Chikungunya virus in Odisha and Maharashtra, India during 2013. Infect. Genet. Evol. 2015, 35:134-141.
92. Schuffenecker I., Iteman I., Michault A., Murri S., Frangeul L., Vaney M.C., Lavenir R., Pardigon N., Reynes J.M., Pettinelli F., Biscornet L., Diancourt L., Michel S., Duquerroy S., Guigon G., Frenkiel M.P., Bréhin A.C., Cubito N., Desprès P., Kunst F., Rey F.A., Zeller H., Brisse S. Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak. PLoS Med. 2006, 3.
93. Sharp T.M., Roth N.M., Torres J., Ryff K.R., Pérez Rodríguez N.M., Mercado C., Pilar Diaz Padró M.D., Ramos M., Phillips R., Lozier M., Arriola C.S., Johansson M., Hunsperger E., Muñoz-Jordán J.L., Margolis H.S., García B.R., Centers for Disease Control and Prevention (CDC) Chikungunya cases identified through passive surveillance and household investigations-Puerto Rico, May 5-August 12, 2014. MMWR Morb. Mortal. Wkly Rep. 2014, 63:1121-1128.
94. Shiferaw B., Lam P., Tuthill S., Choudhry H., Syed S., Ahmed S., Yasmin T. The Chikungunya epidemic: a look at five cases. IDCases 2015, 2:89-91.
95. Simizu B., Yamamoto K., Hashimoto K., Ogata T. Structural proteins of Chikungunya virus. J. Virol. 1984, 51:254-258.
96. Soni M., Singh A.K., Sharma S., Agarwal A., Gopalan N., Rao P.V., Parida M., Dash P.K. Molecular and virological investigation of a focal chikungunya outbreak in northern India. Sci. World J. 2013, 2013:367382.
97. Spissu N., Panichi G., Montisci A., Fiore F. West Nile Virus outbreak in Sardinia, Italy, in 2011. J. Infect. Dev. Ctries. 2013, 7:6-9.
98. Sun Y., Yan J., Mao H., Zhang L., Lyu Q., Wu Z., Zheng W., Feng C., Zhang Y. Characterization of the complete genome of chikungunya in Zhejiang, China, using a modified virus discovery method based on cDNA-AFLP. PLoS ONE 2013, 8.
99. Tamba M., Bonilauri P., Bellini R., Calzolari M., Albieri A., Sambri V., Dottori M., Angelini P. Detection of Usutu virus within a West Nile virus surveillance program in Northern Italy. Vector Borne Zoonotic Dis. 2011, 11:551-557.
100. Thiberville S.D., Boisson V., Gaudart J., Simon F., Flahault A., de Lamballerie X. Chikungunya fever: a clinical and virological investigation of outpatients on Reunion Island, South-West Indian Ocean. PLoS Negl. Trop. Dis. 2013, 7.
101. Thiberville S.D., Moyen N., Dupuis-Maguiraga L., Nougairede A., Gould E.A., Roques P., de Lamballerie X. Chikungunya fever: epidemiology, clinical syndrome, pathogenesis and therapy. Antivir. Res. 2013, 99:345-370.
102. Vega-Rúa A., Zouache K., Girod R., Failloux A.B., Lourenço-de-Oliveira R. High level of vector competence of Aedes aegypti and Aedes albopictus from ten American countries as a crucial factor in the spread of Chikungunya virus. J. Virol. 2014, 88:6294-6306.
103. Volkova E., Frolova E., Darwin J.R., Forrester N.L., Weaver S.C., Frolov I. IRES-dependent replication of Venezuelan equine encephalitis virus makes it highly attenuated and incapable of replicating in mosquito cells. Virology 2008, 377:160-169.
104. Wang D., Suhrbier A., Penn-Nicholson A., Woraratanadharm J., Gardner J., Luo M., Le T.T., Anraku I., Sakalian M., Einfeld D., Dong J.Y. A complex adenovirus vaccine against chikungunya virus provides complete protection against viraemia and arthritis. Vaccine 2011, 29:2803-2809.
105. Wang C., Saborio S., Gresh L., Eswarappa M., Wu D., Fire A., Parameswaran P., Balmaseda A., Harris E. Chikungunya virus sequences across the first epidemic in Nicaragua, 2014-2015. Am.J.Trop. Med. Hyg. 2016, 94:400-403.
106. Wangchuk S., Chinnawirotpisan P., Dorji T., Tobgay T., Dorji T., Yoon I.K., Fernandez S. Chikungunya fever outbreak, Bhutan, 2012. Emerg. Infect. Dis. 2013, 19:1681-1684.
107. Weaver S.C., Forrester N.L. Chikungunya: Evolutionary history and recent epidemic spread. Antiviral Res. 2015, 120:32-39.
108. Weber C., Büchner S.M., Schnierle B.S. A Small Antigenic Determinant of the Chikungunya Virus E2 Protein Is Sufficient to Induce Neutralizing Antibodies which Are Partially Protective in Mice. PLoS Negl. Trop. Dis. 2015, 9. e0003684.
109. Weibel Galluzzo C., Kaiser L., Chappuis F. Reemergence of Chikungunya virus. Rev. Med. Suisse 2015, 6. 11(473):1012, 1014-1016.
110. Wintachai P., Wikan N., Kuadkitkan A., Jaimipuk T., Ubol S. Identification of prohibitin as a Chikungunya virus receptor protein. J. Med. Virol. 2012, 84:1757-1770.
111. Wu D., Zhang Y., Zhouhui Q., Kou J., Liang W., Zhang H., Monagin C., Zhang Q., Li W., Zhong H., He J., Li H., Cai S., Ke C., Lin J. Chikungunya virus with E1-226V mutation causing two outbreaks in 2010, Guangdong, China. Virol. J. 2013, 10:174.
112. Yakob L., Clements A.C. A mathematical model of chikungunya dynamics and control: the major epidemic on Réunion Island. PLoS ONE 2013, 8.